Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2025 ▲▼ | Q4 2025 ▲▼ | Change ▲▼ | Q3 2025 ▲▼ | Q4 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Nuvation Bio Inc.CL A(NUVB) | 8,831,089 | 8,081,089 | -750,000 | $32.68M | $72.41M | 25.27% | +$39.73M |
| BridgeBio Oncology Therapeutics, Inc.(BBOT) | 3,289,661 | 3,289,661 | 0 | $38.09M | $41.19M | 14.37% | +$3.09M |
| Beta Bionics, Inc.(BBNX) | 1,920,125 | 1,316,183 | -603,942 | $38.15M | $40.10M | 14.00% | +$1.95M |
| Bicara Therapeutics Inc. | 2,204,650 | 2,204,650 | 0 | $34.81M | $37.10M | 12.95% | +$2.29M |
| Kestra Med Technologies Ltd SHS | 1,645,893 | 1,373,591 | -272,302 | $39.11M | $36.43M | 12.71% | -$2.68M |
| Upstream Bio, Inc.(UPB) | 1,356,293 | 1,326,293 | -30,000 | $25.51M | $36.01M | 12.57% | +$10.50M |
| enGene Holdings Inc. COM | 526,357 | 876,357 | +350,000 | $3.60M | $7.91M | 2.76% | +$4.32M |
| Alumis Inc. | 653,223 | 653,223 | 0 | $2.61M | $6.38M | 2.23% | +$3.77M |
| Sana Biotechnology, Inc.(SANA) | 843,750 | 843,750 | 0 | $3.00M | $3.43M | 1.20% | +$438.8K |
| ImageneBio, Inc.(IMA) | 455,361 | 455,361 | 0 | $3.71M | $3.14M | 1.10% | -$569.2K |
| Replimune Group, Inc.(REPL) | 248,672 | 248,672 | 0 | $1.04M | $2.42M | 0.84% | +$1.38M |
| enGene Holdings Inc.WARRANT *W EXP 10/31/202 | 89,702 | 0 | -89,702 | $63.4K | $0 | — | -$63.4K |